Can Finerenone Alter Glomerular Disease Trajectory? - Poll - MDSpire

Can Finerenone Alter Glomerular Disease Trajectory?

A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

  • By

  • Kathryn Wighton

  • June 5, 2026

  • 4 min

Share

Original Source(s)

Can Finerenone Alter Glomerular Disease Trajectory?

  • by Kathryn Wighton

  • June 5, 2026

Related Content

FDA Names PreCheck Participants

Seven companies will participate in a two-phase program that provides early FDA technical guidance during development of new US pharmaceutical manufacturing facilities.

FDA Issues CRL for Orviglance NDA

Ascelia Pharma plans to request a Type A meeting with the FDA following receipt of a Complete Response Letter.

Elastography Distinguishes Cardiac Amyloidosis Types

Shear wave velocity measurements in the basal anteroseptal and right ventricular walls differed between transthyretin and light chain cardiac amyloidosis when conventional echocardiographic parameters did not.